Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

NCT01225406 · clinicaltrials.gov ↗

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy

Interventions

DRUG: Tenofovir

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]
[object Object]